Leader in single molecule DNA analysis
IPO:
2015 (NASDAQ: OPGN) Investors:
CHL Medical Partners, Cross Creek Advisors, Harris & Harris Group, Highland Capital Partners, In-Q-Tel, jVen Capital, Mason Wells Biomedical Fund, Merck Global Health Innovation Fund, State of Wisconsin Investment Board, Stonehenge Capital, Versant Ventures, Wisconsin Alumni Research Foundation